"Lovelace Cancer Center, Medical Oncology features a skilled team of accomplished providers dedicated to diagnosing and treating all types of cancer and blood disorders, at all stages. We care about providing you with the best treatment in New Mexico which means the best technology and the best physicians. That's why we, your team and physicians, pride ourselves on a multidisciplinary approach and comprehensive care."

During the past decade, Lovelace Radiation Oncology conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lovelace Radiation Oncology" #1 sponsor was "NRG Oncology" with 4 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "GOG Foundation" with 2 trials sponsored and "Canadian Cancer Trials Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lovelace Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Lovelace Radiation Oncology" are "Anal Basaloid Carcinoma" (2 trials), "Anal Canal Cloacogenic Carcinoma" (2 trials), "Anal Margin Squamous Cell Carcinoma" (2 trials), "Cervical Adenocarcinoma" (2 trials) and "Cervical Adenosquamous Carcinoma" (2 trials). Many other conditions were trialed in "Lovelace Radiation Oncology" in a lesser frequency.

Most popular intervention types in "Lovelace Radiation Oncology" are "Radiation" (12 trials), "Drug" (9 trials), "Other" (6 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "Questionnaire Administration" (3 trials), "Radiation Therapy" (3 trials), "Biospecimen Collection" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lovelace Radiation Oncology" are 8 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Lovelace Radiation Oncology". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Lovelace Radiation Oncology, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lovelace Radiation Oncology, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".